Order Article Reprints

Abreu AdJLd, Mpande CAM, Helble M, Nicholson MW, Cortés MdlÁ, Ponsa MEP, Blumenthal IR, Caccavo F, Pippo T, Rius Sanjuan J, et al. Investment Opportunities for mRNA Technology in Low- and Middle-Income Countries: Key Findings and Future Perspectives. Vaccines. 2025; 13(2):112. https://doi.org/10.3390/vaccines13020112

Abreu, Ariane de Jesus Lopes de, Cheleka A. M. Mpande, Matthias Helble, Martin W. Nicholson, María de los Ángeles Cortés, María Eugenia Pérez Ponsa, Ivan Redini Blumenthal, Francisco Caccavo, Tomas Pippo, Judit Rius Sanjuan, and et al. 2025. "Investment Opportunities for mRNA Technology in Low- and Middle-Income Countries: Key Findings and Future Perspectives" Vaccines 13, no. 2: 112. https://doi.org/10.3390/vaccines13020112

Abreu, A. d. J. L. d., Mpande, C. A. M., Helble, M., Nicholson, M. W., Cortés, M. d. l. Á., Ponsa, M. E. P., Blumenthal, I. R., Caccavo, F., Pippo, T., Rius Sanjuan, J., & Nannei, C. (2025). Investment Opportunities for mRNA Technology in Low- and Middle-Income Countries: Key Findings and Future Perspectives. Vaccines, 13(2), 112. https://doi.org/10.3390/vaccines13020112